Sickle cell anemia is a genetic disorder caused by a particular mutation in the DNA sequence of the hemoglobin gene. Hemoglobin is the protein in red blood cells responsible for oxygen transportation throughout the body.
In sickle cell anemia, a nucleotide base substitution occurs. The mutation replaces adenine with uracil in the DNA, changing the codon from one that specifies glutamic acid to one that specifies valine. This substitution alters the hemoglobin's structure, causing red blood cells to adopt a rigid, sickle-like shape. These misshapen cells can obstruct blood flow, leading to severe pain and potential organ damage.
- Individuals inherit sickle cell anemia in an autosomal recessive manner, meaning they need to inherit two copies of the mutant gene (one from each parent) to express the disease fully.
- Pain episodes, known as "crises," are common symptoms as these sickle-shaped cells block blood vessels.
- Early diagnosis and treatment are vital for managing symptoms and improving quality of life.
Through understanding these mutations, scientists and medical professionals work towards better treatment and potentially curing genetic disorders like sickle cell anemia.